Skip to Content

  • Search

View Additional Section Content

A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients with Diarrhea-Predominant Irritable Bowel Syndrome Protocol Number:27018966IBS3002

Clinical Trial Categories

  • Irritable Bowel Syndrome
Contact
Annette Fudala, RMA, CRC at 215-355-9770

Location

  • Feasterville Family Health Care Center N/A
    1665 Bustleton Pike
    Feasterville, PA 19053

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a Test
Request an Appointment

215-481-EXAM

Clinical Trials Details